Stockholm, March 21st, 2022: Sigrid Therapeutics today announced the publication of a multifaceted, scientific study…

Stockholm, Sweden March 7, 2022. Sigrid Therapeutics, a Swedish healthtech company specializing in the prevention…

Kapitalet kommer från amerikanska, irländska och svenska investerare för att finansiera klinisk studie och internationell…

This financing round was raised from US, Irish and Swedish investors alongside a large-scale industrial…

Swedish Sigrid Therapeutics, which has developed a unique concept to prevent two of the world's…

We are happy to have been profiled in SvD, Sweden's largest daily magazine. Read more…

MedTech Magazine

Breakthrough SiPore15TM silica particle-based diabetes and obesity treatment on track for commercial material scale up…

Life Science Sweden